Table 3.
Risk score: Screen patients with two or more of the following risk factors |
ROC AUC (95% CI) | Sensitivity | Specificity | Patients screened (%) | Patients with DDIs detected (%) | Number of DDIs detected (% of DDIs in cohort) | Contraindicated combinations detected (test sample, 2/500; main sample, 4/2000) |
---|---|---|---|---|---|---|---|
Model 1 | 0.80 (0.76–0.83) | 89.7% | 56.1% | 264 (52.8) | 87 (89.7) | 133 (91.1) | T: 2 |
WHO stage 3–4 | M: 4 | ||||||
anti-infective | |||||||
PI regimen | |||||||
at least two comedications | |||||||
Model 2 | 0.82 (0.79–0.86) | 74.2% | 82.9% | 141 (28.5) | 72 (74.2) | 109 (74.7) | T: 2 |
anti-infective | M: 4 | ||||||
PI regimen | |||||||
at least two comedications | |||||||
Model 3 | 0.69 (0.64–0.73) | 75.2% | 58.5% | 240 (48.0) | 73 (75.3) | 114 (78.0) | T: 2 |
WHO stage 3–4 | M: 3 | ||||||
PI regimen | |||||||
at least two comedications |
T, test sample; M, main sample.